Search Results 211-220 of 17410 for Interferon

1. Celiac Disease Clinical Trials - Mayo Clinic Research

   The purpose of this study is to compare the number of baseline interferon-gamma (IFN-γ) spot forming units (SFUs) to the number of IFN-γ SFUs after a 6-day ...

2. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

   Note: If the QuantiFERON-TB test is indeterminate, a second test should be performed through the central laboratory or local TB interferon gamma release ...

3. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

   ... interferon is not allowed) at study entry and with planned monitoring and management including baseline HBV DNA quantity according to appropriate labeling ...

4. Mycobacterium Avium Complex Pulmonary Infections Systems Biology to Predict Progression and Treatment - Mayo Clinic

   Asymptomatic subjects with diagnosis of LTBI that includes a positive results of a QuantiFERON Gold Plus test or similar Interferon-γ release assay AND a ...

5. A Study to Evaluate Larotrectinib to Treat Patients with Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia - Mayo Clinic

   - Interleukins, interferons and cytokines (other than hematopoietic growth factors): ≥ 21 days after the completion of interleukins, interferon or cytokines ( ...

6. Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS - Mayo Clinic

   Systemic antineoplastic therapy (including cytotoxic chemotherapy, alpha-interferon, kinase inhibitors or other targeted small molecules, and toxin ...

7. A Study to Evaluate Agents to Treat Moderately or Severely Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2 - Mayo Clinic

   ... interferon within 4 weeks or 5 half-lives prior to screening. Steroid dependency defined as need for prednisone at a dose > 10 mg (or equivalent) for > 1 ...

8. Systemic Mastocytosis Clinical Trials - Mayo Clinic Research

   The dose of Tamoxifen will be 20 mg/day and the duration of treatment will be for one year. Patients currently taking interferon alfa, imatinib mesylate, or ...

9. A Study To Assess The Effectiveness And Safety Of Pacritinib In Patients With VEXAS Syndrome (PAXIS) - Mayo Clinic

   Positive Quantiferon (or other interferon gamma release assay) during Screening. Note: patients with indeterminant Quantiferon results may enroll. Known ...

10. Publications - W Ray Kim, M.D. - Mayo Clinic

    Potential Efficacy of Pegylated Interferon-alpha and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B. Gut Liver. 2016 ...